PhD in Surgery and Hepatobiliary and Pancreatic Diseases (last intake in 2013)

Course partially running (all years except the first)


Withing general surgery, the teaching methods will deal with treating complex surgical patients (metabolic and hormonal alteration in the surgical sepsis; nutritional support for critical surgical patients; epidemology and analysis of risk factors for hepatic and renal failure; infections in surgical patients); surgical treatment of obesity (gastroplasty, gastric banding, gastric bypass: physiological alteration of gastric secretion and esophageal motility in the various techniques used for treating obesity; checking the ponderal loss in the various techniques, in particular in relationship with the BMI and adipose cells in the patient; histologic alterations in the esophageal, gastric and duodenal mucous after gsatric procedures); laparoscopic surgery (laparoscopic feasibility in treating hepatobiliary-pancreatic illnesses; study of the advantages and limitations of applying laparoscopy to hepatic-biliary-pancreatic surgery). In the field of malformative paediatric surgery: short gut syndrome in paediatric age and its repercusssions on the developing age; preventive treatment in secondary cryptorchidism and varicocele male sterility. In the field of vascular surgery: evaluation of traditional surgical and endovascular approaches in treating vascular disorders; evaluation of methods to prevent precocious intraoperative embolism during traditional surgery and endovascular treatment; evaluation of the comparative results of traditional surgery and endovascular treatment; study into the possibility of using stem cells in diabetic arteriopathy. In the pancreatic field: epidemological study of acute and chronic pancreatitis; etiopathogenesis of chronic pancreatitis, with special focus on auto-immune and genetic genesis; diagnostics of acute and chronic pancreatitis; diagnosis and surgical and oncological treatment of pancreatic tumours. The research methods will involve the techniques of histology, immune-histochemistry and molecular biology. In the hepatic field: clinic and treatment of chronic viral hepatitis (clinical aspects: evaluation of the clinic development of compensated cirrhosis associated with virus B infection (HBsAg positive) and with virus C (anti-HVC positive), in particular the incidence of complications and liver tumour and the survival level in Europe; evaluation of the role of various genotypes of virus C on the clinical development of chronic liver disease caused by virus C, likewise other prognostic factors, including the role of previous infection from hepatitis B virus; treatment aspects: evaluation of the long-term effectiveness of anti-viral treatment using IFN-alfa in chronic virus B and C liver diseases, with special focus on objectives of clinical importance, such as the prevention of complications developing (hepatic decomposure and liver tumour) and the increased survival level; evaluation of the effectiveness of treatment with a combination of IFN-alfa and ribavirin, an anti-viral drug, in patients with chronic virus C hepatitis who relapse or who do not respond to treatment cycles with IFN-alfa; surgical and oncological treament of liver tumour). Title "Information for the students".

Course details

Degree type
3 years
Supervisory body
Teachers' Committee in the Master in Surgical Science and Hepatobiliary and Pancreatic Illnesses
Graduate School
Translational Biomedical Sciences
Main Department
Surgery, Dentistry, Paediatrics and Gynaecology
Macro area
Life and Health Sciences